Tonix Pharmaceuticals Holding Corp (TNXP)
Tonix Pharmaceuticals Announces Licensing TNX-4900, a Selective Sigma-1 Receptor Antagonist for Chronic Neuropathic Pain from Rutgers University
Tonix Pharmaceuticals Announces Licensing TNX-4900, a Selective Sigma-1 Receptor Antagonist for Chronic Neuropathic Pain from Rutgers University
Insulet - Insulet to Participate in 44th Annual J.P. Morgan Healthcare Conference
Energous’ PowerBridge Pro Gains EU Approval, Unlocking Wireless Power in Europe
Glaukos Announces Participation in J.P. Morgan Healthcare Conference
Pfizer Inc. - Pfizer Reaffirms Full-Year 2025 EPS Guidance and Provides Full-Year 2026 Guidance
Pfizer Reaffirms Full-Year 2025 EPS Guidance and Provides Full-Year 2026 Guidance
Organigram Reports Record Fourth Quarter and Fiscal 2025 Results
Warrant Prospectus Related to Convertible Note Agreements
Grifols Communication - Grifols obtains approval from the EMA for the entire value chain of Grifols Egypt
Subcutaneous Saphnelo approved in EU